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a  b  s  t  r  a  c  t
Chagas’  disease  is a  parasitic  infection  caused  by protozoan  Trypanosoma  cruzi  that  affect  millions  of
people  worldwide.  The  available  drugs  for treatment  of this  infection  cause  serious  side  effects  and  have
variable  efﬁcacy,  especially  in  the  chronic  phase  of the disease.  In this  context,  natural  compounds  have
shown  great  potential  for the  discovery  of  new  chemotherapies  for the  treatment  of this  infection  and
various  other  diseases.  In  present  study,  we  evaluated  the  in  vitro  antiprotozoal  activity  of  ﬁve  species  of
Brazilian  and  Spanish  marine  sponges  (Condrosia  reniformes,  Tethya  rubra,  Tethya  ignis,  Mycale  angulosa
and  Dysidea  avara)  against  T. cruzi.  By  GC–MS  data,  we  observed  that in  these  extracts  were  present  the
major  classes  of  the  following  compounds:  hydrocarbons,  terpenes,  steroids  and alcohols.  The  extracts
showed  activity  against  the  three  forms  of this  parasite  and  did  not  induce  toxicity  in mammalian  cells.arine sponges
Better  activities  were  observed  with  the extracts  of  marine  sponges,  C. reniformes  (EC50 = 0.6 g/ml),  D.
avara  (EC50 =  1.1  g/ml)  and  M.  angulosa  (EC50 =  3.8 g/ml),  against  trypomastigote  forms.  In intracellular
amastigote  forms,  the  extract  of T. ignis  showed  IC50 of  7.2  g/ml and  SI  of  24.65.  On  this  basis,  our results
indicate  that  these  extracts  can be  promising  chemotherapeutic  agents  against  T.  cruzi.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Chagas’ disease or American trypanosomiasis is caused by
nicellular parasite Trypanosoma cruzi. Estimates indicate that it
ffects about 6–7 million people worldwide, mainly in Latin Amer-
ca (WHO, 2015). This infection is characterized by two clinical
hases: acute phase, deﬁned by high parasitemia, and a long and
rogressive chronic phase that can manifest symptoms after some
ears (Annang et al., 2015). Two drugs are used to treat infected
atients, benznidazole and nifurtimox (Maya et al., 2007). Both fea-
ure high toxicity and limited therapeutic potential (Maya et al.,
007). These facts make the search for new therapeutic alternatives
hat are more effective as an urgent need (Valdez et al., 2012).
Many studies show that natural products have great poten-
ial for the treatment of infectious diseases (Izumi et al., 2012).
∗ Corresponding author.
E-mail: cvnakamura@uem.br (C.V. Nakamura).
http://dx.doi.org/10.1016/j.bjp.2015.08.011
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier EditoraThese products have in their composition a richness of secondary
metabolites, as terpenes, steroids, polyketides, peptides, alkaloids
and porphyries (Torres et al., 2014). Among the natural products,
the marine biodiversity stands out for possessing substances with
activity of interest; although, oftentimes, little is known about them
(Ferreira et al., 2014).
The marine sponges exhibit many biological activities that are
of potential pharmacological importance, such as antiviral, anti-
cancer, antiprotozoal, antifungal and anti-inﬂammatory (Mehbub
et al., 2014). These organisms are primitive metazoa, sessile and so
exhibit defense chemical substances that protect them from preda-
tors (Sepcic et al., 2010). Symbiotic associations between marine
sponges and microorganisms can lead to the production of sec-
ondary metabolites that are biologically active, making sponges
promising candidates for the treatment of various diseases (Thomas
et al., 2010).
Based on this context, the purpose of the present study was
to evaluate the trypanocidal activity in vitro of crude extracts of
ﬁve species of Brazilian and Spanish marine sponges (Condrosia
 Ltda. All rights reserved.
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Box 1 Marine sponges collected in Brazilian and Spanish
Coasts for biological assays.
Specie Collection local Taxonomy (Order,
Family)
T. rubra Baía de Todos os Santos,
Salvador, Bahia, BR
Hadromerida,
Tethyidae
C.  reniformes Punta Santana, Blanes,
Catalun˜a, SP
Chondrosida,
Chondriliidae
D.  avara Medas, Catalun˜a,
Mediterrâneo, SP
Dictyoceratida,
Dysideidae
T.  ignis Praia do Bonﬁm, Angra dos
Reis, Rio de Janeiro, BR
Poecilosclerida,
Tedaniidae
M.  angulosa Praia do Bonﬁm, Angra dos Poecilosclerida,
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eniformes,  Tethya rubra, Tethya ignis, Mycale angulosa and Dysidea
vara) in order to ﬁnd more effective and less toxic alternative
herapies for Chagas’ disease.
aterials and methods
ponges collection and identiﬁcation
Five species of sponges were collected through free diving and
CUBA diving, from tide zone to 19 m depth at Brazilian and Spanish
oasts (Box 1).
reparation of extracts
After collection, sponge species were immediately frozen and
hen lyophilized. Freeze dried materials (100 g) were extracted at
oom temperature by maceration with acetone three times for a
eriod of 72 h. The crude extracts obtained were evaporated to
ryness under low temperatures (<50 ◦C) on a rotary evaporator.
as chromatography–mass spectrometry (GC–MS) analyses
The acetone crude extracts of ﬁve species of Brazilian and Span-
sh marine sponges (C. reniformes,  T. rubra, T. ignis, M. angulosa
nd D. avara) were analyzed by gas chromatography coupled with
ass spectrometry (GC–MS) in the apparatus of Shimadzu QP
010 in an operating system via electron impact (70 eV) equipped
ith gun Split (gas chromatography 260 ◦C). DB-5 MS  column
as used (30 m × 0.25 mm × 0.25 m),  Agilent J&W GC Columns,
sing helium as the carrier gas; the column ﬂow was  1.3 ml/min,
njection volume was 1 l, injector temperature was 260 ◦C and
ressure was 97.4 kPa. A mixture of (C9–C20, C21–C40) linear
ydrocarbons was injected under the same conditions to identify
he components. The spectra obtained were compared with the
atabase of equipment (FFNSC1.3.lib, WILEY7.LIB, NIST08s.LIB, MY
IBRARY.lib).
arasites and cells
Epimastigote forms of T. cruzi (Y strain) were maintained at 28 ◦C
or 96 h in liver infusion tryptose medium (LIT) supplemented with
0% fetal bovine serum (FBS).
Epithelial cells from the kidney of the monkey Macaca mulatta
LLCMK2 cells) were maintained in Dulbecco’s modiﬁed Eagle’s
edium (DMEM) supplemented with 2 mM l-glutamine, 10% FBS
◦t 37 C, and buffered with sodium bicarbonate in a humidiﬁed
% CO2 atmosphere. After monolayer formation, the cells were
nfected with 5 × 106 trypomastigotes/ml. Extracellular parasites
ere removed after 24 h, the cells washed, and these cultures werearmacognosia 25 (2015) 651–656
maintained in DMEM medium containing 10% FBS, until trypomas-
tigotes emerged from the infected cells.
Antiproliferative activity on epimastigote forms
Epimastigote forms cultivated for 96 h (phase log) were adjusted
to a ﬁnal inoculum of 1 × 106 parasites/ml in LIT medium with
10% FBS. Afterwards, they were added to the wells of a 24-well
microplate that contained increasing concentrations of compounds
(10, 25, 50, 100, and 200 g/ml), diluted in dimethyl sulfoxide
(DMSO) and LIT medium. The assay was incubated at 28 ◦C for
96 h. After incubated, cell density was  measured by counting in
a Neubauer’s chamber. Antiproliferative activity was  expressed as
the percentage of growth inhibition compared with control para-
sites grown in LIT medium. The concentration able to inhibit 50%
of the parasites (IC50) was  expressed by linear regression.
Assay cytotoxicity in LLCMK2 cells
The LLCMK2 cells were distributed in 96-well microplate at
a concentration of 2.5 × 105 cells/ml in DMEM medium supple-
mented with 10% FBS and then incubated at 37 ◦C in a humidiﬁed 5%
CO2 atmosphere for 24 h. Afterwards, the compounds were added
in the concentration desired (50, 100, 150, 250 and 350 g/ml),
diluted in dimethyl sulfoxide (DMSO) and DMEM medium and
incubated for 96 h at 37 ◦C in a humidiﬁed 5% CO2 atmosphere.
After incubation, the cells were washed with PBS and a solution
of 2 mg/ml  MTT  was added. This assay was incubated for 4 h at
37 ◦C in 5% CO2 atmosphere. DMSO was added to each well to stop
the reaction, and absorbance was read at 492 nm using a BIO-TEK
Power Wave XS spectrophotometer. Then, the selective index (SI),
that indicates the toxicity of the parasite compared to the host, was
calculated.
Assay cytotoxicity in erythrocytes
Human blood A+ type without anticoagulant was  collected and
homogenized in Erlenmeyer ﬂask with glass beads. The blood was
centrifuged in saline and the cells were distributed into Eppendorf
tubes with the desired concentration of the compounds (10, 50, 100,
500, 1000 g/ml). The samples were incubated at 37 ◦C for 120 min.
Afterwards, the test sample was  centrifuged and the supernatants
were transferred to 96-well plates. The absorbance was read at
540 nm using a BIO-TEK Power Wave XS spectrophotometer.
Evaluation of trypomastigote motility
Trypomastigote forms, in concentration of 1 × 107 parasites/ml,
were resuspended in DMEM medium and added in duplicate to
each well of a 96-wellmicro plate, in presence of different con-
centrations of the compounds (0.1, 1, 5, 10 and 25 g/ml). The
assay was  incubated for 24 h at 37 ◦C in a humidiﬁed 5% CO2 atmo-
sphere. The results were obtained by observing motility, allowing
the determination of the viability of the parasites, using the
Pizzi–Brener method (Brener, 1962). For this, an aliquot of 5 l of
each sample was placed on slides plus coverslips and immediately
counted by optical microscopy; subsequently, the concentration
that lysed 50% of the parasites value (EC50) was calculated.
Activity against intracellular amastigote forms
To evaluate the effects of compounds on the intracellular
amastigote forms, a suspension of 2.5 × 10 cells/ml in DMEM
medium supplemented with 10% FBS was seeded in 24-well
microplates that contained round coverslips and then maintained
at 37 ◦C in a 5% CO2 atmosphere for 24 h until a monolayer was
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Table  1
Compound GC–MS data observed in bioactivity crude extracts of ﬁve species of Brazilian and Spanish marine sponges (C. reniformes, T. rubra, T. ignis, M.  angulosa and D.
avara).
Peak RT Compounds IS (%) Area (%) Observed (m/z) Molecular
formula
Da. Ma.  Cr. Tr. Tig.
1 26.1 dodecanal 96 1.60 184 C12H24O +
2  26.2 4-ethyloctanoic acid 87 2.75 172 C10H20O2 +
3  27.4 hexadecan-1-ol 98 3.61 242 C16H34O +
4  2
8.1
octadecanal 96 2.95 268 C18H36O +
5  40.0 (Z)-octadec-13-enal 95 1.85 266 C18H34O +
6  42.08 (3E)-3-ethyl-2-methyl-1,3-
hexadiene
81 9.35 124 C9H16 +
7  42.4 2-furoic acid,
2-methyloct-5-yn-4yl ester
80 87.13 234 C14H18O3 +
8  42.7 octadecanamide 91 2.50 283 C18H37NO +
9  44.0 4,6-cholestadien-3-ol 93 7.71 384 C27H44O + + +
10  46.7 (3S,8S,9S,10R,13R,14S,17R)-
17-[(E,2R,5S)-5-ethyl-6-
methylhept-3-en-2-yl]-
10,13-dimethyl-
2,3,4,7,8,9,11,12,14,15,16,17-
dodecahydro-1H-
cyclopenta[a]phenanthren-
3-ol
92 1.54 412 C29H48O + + +
11  46.8 1-hexadecyne 82 1.98 222 C16H30 +
12  47.2 (3)-cholest-5-en-3-ol 93 60.47 386 C27H46O + + + +
13  47.7 24-methyl
cholest-5,22-dien-3-ol
88 5.57 398 C28H46O + + + +
14  47.9 (20R)-cholesta-3,5-diene 96 4.83 368 C27H44 +
15  47.9 cholesterol,
pentaﬂuoropropionate
90 2.67 532 C30H45F5O2 +
16  48.3 3,5-cholestadien-7-one 92 14.36 382 C27H42O + + +
17  48.4 gorgost-5-en-3-ol,(3)- 82 2.20 426 C30H50O +
18  48.5 stigmasta-5,24(28)-dien-3-
ol;
5,24[28]-Stigmastadien-
3-ol;
3-hydroxy-5,24[28]-
stigmastadiene
85 29.35 412 C29H48O +
19  48.5 22-dihydrobrassicasterol 88 1.35 400 C28H48O +
20  48.8 (7)-7-hydroxycholest-4-
en-3-one
88 1.05 384 C27H44O +
21  49.2 4,6-cholestadien-3-one 80 1.92 382 C27H42O +
22  49.6 17-(5-ethyl-6-
methylheptan-2-yl)-10,13-
dimethyl-
2,3,4,7,8,9,11,12,14,15,16,17-
dodecahydro-1H-
cyclopenta[a]phenanthren-
3-ol
95 10.88 414 C29H50O + + +
23  50.7 stigmasta-3,5-dien-7-one 83 7.49 410 C29H46O +
24  50.78 (1,2,5)-1,2-
epoxycholestan-3-one
80 2.51 400 C27H44O2 +
25  51.00 5-cholesten-3-ol-7-one 81 3.90 400 C27H44O2 +
26  51.0 (3S,8S,9S,10R,13R,14S,17R)-
17-[(2R,5R)-5,6-
dimethylheptan-2-yl]-
10,13-dimethyl-
2,3,4,7,8,9,11,12,14,15,16,17-
dodecahydro-1H-
cyclopenta[a]phenanthren-
92 8.89 400 C28H48O + +
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T, retention time; IS (%), index of similarity; (+), occurrence, Cr., C. reniformes; Tr., 
btained. Afterwards, trypomastigote forms were added to the
ells at a concentration of ten parasites by host cell. After 24 h, non-
nternalized parasites were removed and the cells were incubated
n presence of different concentrations of the compounds (12.5, 25,
0, 75 and 100 g/ml) for 96 h at 37 ◦C in a 5% CO2 atmosphere.
he coverslips were ﬁxed with methanol and stained with Giemsa,
nd permanently mounted with Entellan (Merck, Darmstadt, Ger-
any). A total 200 cells were counted using light microscope and
he percentage of infected cells and number of intracellular para-
ites were estimated. The survival index (percentage of infecteda; Tig., T. ignis; Ma., M.  angulosa; Da., D. avara.
cells × number of amastigotes per cell) and IC50 value were then
determined.
Results
Compound GC–MS dataFrom compound identiﬁcation using GC–MS data, 26 chemical
compounds of the following classes were identiﬁed: hydrocarbons,
terpenes, steroids and alcohols, as major compounds, in extracts of
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Fig. 1. Chromatogram GC–MS of compounds identiﬁed from ﬁve species of Brazilia
ve species of Brazilian and Spanish marine sponges (C. reniformes,
. rubra, T. ignis, M.  angulosa and D. avara) (Fig. 1).
Among the chemical compounds identiﬁed are: 4,6-
holestadien-3ˇ-ol; (3S,8S,9S,10R,13R,14S,17R)-17-[(E,2R,5S)-5-
thyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,
4,15,16,17 dodecahydro-1H-cyclopenta[a]phenanthren-3-ol (st-
gmasterol); 17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-
,3,4,7,8,9,11,12,14, 15,16,17-dodecahydro-1H-cyclopenta[a]ph-
nanthren-3-ol (-sitosterol); (3)-cholest-5-en-3-ol; 24-methyl
holest-5,22-dien-3-ol (brassicasterol) (Table 1).
ffect of extracts on growth of epimastigotes T. cruzi
All the extracts tested showed activity against epimastigote
orms (Table 2). The extracts of D. avara, M.  angulosa and C.
eniformes were most active, with IC50 values of 23.4, 67.3 and
8.6 g/ml, respectively. Greater concentrations of T. ignis and T.
ubra were needed to inhibit parasite proliferation in 50%, 124.7
nd 109.9 g/ml, respectively.
ffect of extracts on toxicity in mammalian cells
The extracts of marine sponges showed no toxic effects in
LCMK2 cells at concentrations that inhibited 50% of the parasites.
he most toxic extract was C. reniformes with CC50 of 79.8 g/ml.
he extracts of T. ignis, T. rubra and D. avara showed CC50 of 177.5,
72.5 and 144.2 g/ml, respectively. However, the less toxic extract
as of M.  angulosa with CC50 of 302.7 g/ml (Table 2).40.0 50.0 60.055.045.0
 Spanish marine sponges (C. reniformes, T. rubra, T. ignis, M.  angulosa and D. avara).
In human red blood cells, it was observed that the concentration
to haemolyse 50% of the erythrocytes was  higher than 1000 g/ml.
Effect of extracts on viability of trypomastigotes T. cruzi
The non-proliferative infective forms of T. cruzi, trypomastigo-
tes, were sensitive to the presence of different concentrations of
marine sponge extracts (Table 2). The extracts of T. ignis, D.  avara,
M. angulosa and C. reniformes showed EC50 of 6.3, 1.1, 3.8 and
0.6 g/ml, respectively. For marine sponge T. rubra, the concentra-
tion that lysed 50% of trypomastigotes was 22.3 g/ml.
Effect of extracts on growth of amastigotes T. cruzi
All the extracts of the marine sponge studied showed inhibitory
activity on amastigote forms (Table 2). The extract of T. rubra, D.
avara, M. angulosa and C. reniformes showed IC50 of 44.5, 40.3, 55.5
and 82.6 g/ml, respectively. However, the better IC50 observed
(7.2 g/ml) was with the extract obtained from T. ignis.
Discussion
The marine biodiversity is a promising source of natural prod-
ucts with remarkable biological activity (Napolitano et al., 2009).
Studies with marine sponges are yielding 200 new pharmaco-
logically active metabolites every year (Turk et al., 2013). These
organisms are ancient and some of them contain diverse groups
of metabolically active compounds (Santalova et al., 2004). In that
way, the identiﬁcation of biological activity of extracts obtained
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Table  2
Activity values of extracts of marine sponges on epimastigote, trypomastigote and amastigote forms of T. cruzi, cytotoxicity in mammalian cells and selectivity index.
Extracts Epimastigote (IC50) Trypomastigote (EC50) Amastigote (IC50) LLCMK2 (CC50) SI (CC50/EC50 Trypo) SI (CC50/IC50 Ama)
T. ignis 124.7 ± 10.2 6.3 ± 0.1 7.2 ± 5.2 177.5 ± 73.5 28.0 24.6
T.  rubra 109.9 ± 3.4 22.3 ± 1.1 44.5 ± 11.6 172.5 ± 14.5 7.7 3.9
D.  avara 23.4 ± 0.4 1.1 ± 0.2 40.3 ± 0.3 144.2 ± 0.9 127.6 3.6
M.  angulosa 67.3 ± 12.2 3.8 ± 2.2 55.5 ± 8.5 302.71 ± 17.5 79.6 5.4
C.  reniformes 28.6 ± 1.6 0.6 ± 0.1 82.6 ± 10.3 79.8 ± 8.5 133.0 1.0
V %; EC5
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ndex  between host cell LLCMK2 and parasites.
rom marine sponges and other marine organisms is important for
solate compounds with potential biomedical action (Sepcic et al.,
997).
Some compounds, identiﬁed by GC–MS in marine sponges stud-
ed (C. reniformes,  T. rubra, T. ignis, M.  angulosa and D. avara),
re widely known in the literature for the biological activities, as
ntiprotozoal activity (Torres et al., 2014), which justiﬁes this study.
or example, the steroids, stigmasterol, -sistosterol and brassicas-
erol, are found in larger quantities in organic extracts and show
ctivity against T. cruzi (Herrera et al., 2008; Moreira et al., 2009;
antalova et al., 2004; Visbal et al., 2011).
Here, the extract studies revealed potent activity in epi-
astigote, trypomastigote and amastigote forms of T. cruzi. The
ntitrypanosomal activity in epimastigote forms showed great
ariations in the IC50 values. These variations in activity also
ere observed against T. brucei rhodesiense, T. cruzi, Leishmania
onovani and Plasmodium falciparum treated with sponge-derived
ompounds (Orhan et al., 2010). Furthermore, the extracts showed
ronounced activity on trypomastigote forms, the same as
bserved by Izumi et al. (2011), in which the isolation of methano-
ic extract of Piptadenia africana (Mimosaceae) showed a EC50
f 4.0 g/ml. The SI found was considered excellent, similar to
he results obtained in literature with organic extracts of several
arine sponges (Hoet et al., 2004; Perdicaris et al., 2013). Interest-
ngly, T. ignis exhibited a remarkable IC50 against amastigote forms,
hich can be better exploited, due the lack of efﬁcacy of chemother-
peutic agents available in the chronic phase of Chagas’ disease
Garcia et al., 2005). Additionally, the SI showed that the extracts
ere more toxic to the parasites than to LLCMK2 cells. Although,
cetone extracts can have high levels of hemolytic activity (Sepcic
t al., 2010), the extracts studied showed hemolysis in human cells
nly in high concentrations (>1000 g/ml).
onclusion
In conclusion, the marine sponge’s species tested in the current
tudy showed relevant activity against T. cruzi opening the way
or bioguided fractionation and isolation of bioactive components.
hus, these extracts may  lead to important advances in the devel-
pment of new chemotherapies in the treatment of patients with
hagas’ disease.
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